Jan 31 (Reuters) - A lawsuit accusing a former GlaxoSmithKline (GSK.L), opens new tab unit and Pfizer (PFE.N), opens new tab of misleading consumers by marketing some ChapStick products as “all ...
For the past two years, plaintiffs' lawyers have nourished Washington Legal Foundation commentators here at Forbes.com with a steady diet of all-natural lawsuits. And by that we mean class actions ...
The company's CEO says the case is based on bad science and the wrong testing method.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results